downsides of glp 1 Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks Study identifies benefits, risks linked
Description
What is a GLP-1 Receptor Agonist
A dual GIP/GLP-1 agonist studied in metabolic research
Background Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular diseases (CVD)
fewer (1 in 2) people 65 and older felt the drugs were effective for them
Only one of those is GLP-1
[Feldman, Marie, Dalyai, Jodi] on Amazon.com
